298 related articles for article (PubMed ID: 22556133)
1. Mammalian target of rapamycin integrates diverse inputs to guide the outcome of antigen recognition in T cells.
Waickman AT; Powell JD
J Immunol; 2012 May; 188(10):4721-9. PubMed ID: 22556133
[TBL] [Abstract][Full Text] [Related]
2. mTOR signaling at the crossroads of environmental signals and T-cell fate decisions.
Huang H; Long L; Zhou P; Chapman NM; Chi H
Immunol Rev; 2020 May; 295(1):15-38. PubMed ID: 32212344
[TBL] [Abstract][Full Text] [Related]
3. mTOR and other effector kinase signals that impact T cell function and activity.
Myers DR; Wheeler B; Roose JP
Immunol Rev; 2019 Sep; 291(1):134-153. PubMed ID: 31402496
[TBL] [Abstract][Full Text] [Related]
4. mTOR, metabolism, and the regulation of T-cell differentiation and function.
Waickman AT; Powell JD
Immunol Rev; 2012 Sep; 249(1):43-58. PubMed ID: 22889214
[TBL] [Abstract][Full Text] [Related]
5. TCR engagement increases hypoxia-inducible factor-1 alpha protein synthesis via rapamycin-sensitive pathway under hypoxic conditions in human peripheral T cells.
Nakamura H; Makino Y; Okamoto K; Poellinger L; Ohnuma K; Morimoto C; Tanaka H
J Immunol; 2005 Jun; 174(12):7592-9. PubMed ID: 15944259
[TBL] [Abstract][Full Text] [Related]
6. mTOR signaling in the differentiation and function of regulatory and effector T cells.
Zeng H; Chi H
Curr Opin Immunol; 2017 Jun; 46():103-111. PubMed ID: 28535458
[TBL] [Abstract][Full Text] [Related]
7. The duration of T cell stimulation is a critical determinant of cell fate and plasticity.
Miskov-Zivanov N; Turner MS; Kane LP; Morel PA; Faeder JR
Sci Signal; 2013 Nov; 6(300):ra97. PubMed ID: 24194584
[TBL] [Abstract][Full Text] [Related]
8. Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain.
Finney HM; Akbar AN; Lawson AD
J Immunol; 2004 Jan; 172(1):104-13. PubMed ID: 14688315
[TBL] [Abstract][Full Text] [Related]
9. A role for mammalian target of rapamycin in regulating T cell activation versus anergy.
Zheng Y; Collins SL; Lutz MA; Allen AN; Kole TP; Zarek PE; Powell JD
J Immunol; 2007 Feb; 178(4):2163-70. PubMed ID: 17277121
[TBL] [Abstract][Full Text] [Related]
10. Induction of granzyme B expression in T-cell receptor/CD28-stimulated human regulatory T cells is suppressed by inhibitors of the PI3K-mTOR pathway.
Efimova OV; Kelley TW
BMC Immunol; 2009 Nov; 10():59. PubMed ID: 19930596
[TBL] [Abstract][Full Text] [Related]
11. Regulation and function of mTOR signalling in T cell fate decisions.
Chi H
Nat Rev Immunol; 2012 Apr; 12(5):325-38. PubMed ID: 22517423
[TBL] [Abstract][Full Text] [Related]
12. mTOR: taking cues from the immune microenvironment.
Delgoffe GM; Powell JD
Immunology; 2009 Aug; 127(4):459-65. PubMed ID: 19604300
[TBL] [Abstract][Full Text] [Related]
13. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation.
Vespa GN; Lewis LA; Kozak KR; Moran M; Nguyen JT; Baum LG; Miceli MC
J Immunol; 1999 Jan; 162(2):799-806. PubMed ID: 9916701
[TBL] [Abstract][Full Text] [Related]
14. Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin.
Colombetti S; Basso V; Mueller DL; Mondino A
J Immunol; 2006 Mar; 176(5):2730-8. PubMed ID: 16493028
[TBL] [Abstract][Full Text] [Related]
15. The Regulatory Effects of mTOR Complexes in the Differentiation and Function of CD4
Wang P; Zhang Q; Tan L; Xu Y; Xie X; Zhao Y
J Immunol Res; 2020; 2020():3406032. PubMed ID: 32377533
[TBL] [Abstract][Full Text] [Related]
16. Negative regulation of mTOR activation by diacylglycerol kinases.
Gorentla BK; Wan CK; Zhong XP
Blood; 2011 Apr; 117(15):4022-31. PubMed ID: 21310925
[TBL] [Abstract][Full Text] [Related]
17. mTOR signaling disruption from myeloid-derived suppressive cells protects against immune-mediated hepatic injury through the HIF1α-dependent glycolytic pathway.
Chen X; Zhang Z; Bi Y; Fu Z; Gong P; Li Y; Yu Q; Jia A; Wang J; Xue L; Yang H; Liu G
J Leukoc Biol; 2016 Dec; 100(6):1349-1362. PubMed ID: 27462101
[TBL] [Abstract][Full Text] [Related]
18. mTOR signaling in T cell immunity and autoimmunity.
Liu Y; Zhang DT; Liu XG
Int Rev Immunol; 2015 Jan; 34(1):50-66. PubMed ID: 25019278
[TBL] [Abstract][Full Text] [Related]
19. TCR signaling for initiation and completion of thymocyte positive selection has distinct requirements for ligand quality and presenting cell type.
Yasutomo K; Lucas B; Germain RN
J Immunol; 2000 Sep; 165(6):3015-22. PubMed ID: 10975810
[TBL] [Abstract][Full Text] [Related]
20. mTOR Signaling pathway as a master regulator of memory CD8
Rostamzadeh D; Yousefi M; Haghshenas MR; Ahmadi M; Dolati S; Babaloo Z
J Cell Physiol; 2019 Aug; 234(8):12353-12368. PubMed ID: 30710341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
